The vision is to build a world-leading immuno-oncology company that brings safe and effective vaccines to the patients. We will reach that by executing on different activities.
Very strong preclinical data: Remove tumors and make animals immune to new cancers – and also utilizes the gold-standard for vaccine delivery technology into the cancer immunotherapy field.
Treating cancer by targeting tumor viruses within our genome since current treatment methods are not only unsatisfactory but also extremely harsh on the patient and his/her life quality.
THE ROAD FORWARD
Ambitious milestones are to be achieved in the coming 12 to 18 months – preparing the company for future VC funding, GMP and clinical trials in collaboration with leading clinical experts.